Science Speaks is in Atlanta, Georgia this week and will be live-blogging from the 20th CROI — Conference on Retroviruses and Opportunistic Infections from Sunday to Wednesday, covering breaking developments from investigators on cure research, new antiretroviral agents, hepatitis, tuberculosis and treatment as prevention. ATLANTA, GA — Robert Grant from University of California at San [...]
Science Speaks is in Atlanta, Georgia this week and will be live-blogging from the 20th CROI — Conference on Retroviruses and Opportunistic Infections from Sunday to Wednesday, covering breaking developments from investigators on cure research, new antiretroviral agents, hepatitis, tuberculosis and treatment as prevention. Perhaps at some point what the VOICE trial (Vaginal and Oral [...]
On the eve of Secretary Hillary Clinton’s release of the first United States global AIDS response strategy, two reports released in recent days give a look not only of the progress so far, but of the shortfalls the new plan must address. Achieving the End, One Year and Counting, from AVAC, looks at the scientific [...]
Dr. Rochelle Walensky has been a member of the Cost-effectiveness of Preventing AIDS Complications (CEPAC) team since 1998. She is a member of the Office of AIDS Research Advisory Council at the National Institutes of Health and the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Dr. Walensky has [...]
San Diego, CA — At a symposium entitled “Challenges and Opportunities in HIV Prevention today at ID Week, Jean Marrazzo offered a summation of the pre-exposure phophylaxis (PrEP) research findings and highlighted some of the nuances and unanswered questions about disparate study results. She began by defining the now widely used term “biomedical prevention” as [...]
Dr. Myron S. Cohen is the architect and principal investigator of the multinational HPTN 052 trial, which demonstrated that antiretroviral treatment prevents the sexual transmission of HIV-1. This work was recognized by Science Magazine as the “Breakthrough of the Year” in 2011. His research focuses on the transmission and prevention of transmission of HIV, and [...]
The U.S. Department of Defense and Global Health: It is the oldest agency in the United States, has a reach that extends effectively to all countries, is involved in health service delivery and health research, but is not budgeted as a global health agency, nor is global health considered its mission. All the same, the [...]
In the global AIDS epidemic, it is the illustration of a vicious circle: People in situations that leave them the most vulnerable to getting HIV have the least access to protection. They have the highest prevalence of the virus that leads to AIDS. Then they have the least access to care. That may not be [...]
A look at the recent AIDS Vaccine 2012 Conference shows range of prevention developments The following is a guest post from Margaret McGlynn, president and CEO of the International AIDS Vaccine Initiative (IAVI) and William Snow, director of the Global HIV Vaccine Enterprise. More than 1,000 HIV researchers and other professionals involved in HIV prevention [...]
New approaches to disease treatment and prevention, as well as failures in old approaches are part of what we’re reading this week . . . NIH-Funded analysis estimates effective PrEP dosing for men who have sex with men: An analysis of data from the iPrEx study looked at the amount of the antiretroviral medicine [...]
HIV
With the groundwork for treatment provided through the President’s Emergency Plan For AIDS Relief having been laid in the first expensive years of country programs, with the purchases of generic antiretroviral drugs, and with economies of scale as the numbers of people enrolled in treatment increased, PEPFAR has reduced per patient treatment costs in recent [...]
Tuberculosis
A group of tuberculosis community activists is taking their quest for representation in responses to TB global, joining efforts across borders to make their voices heard, an announcement this week says. The Global Coalition of TB Activists came together at a February Stop TB Partnership meeting in Geneva, the announcement says, with the aim of [...]
Research & Development
What would people living with HIV do differently if they knew that they could be infected again, with a new strain, that could complicate both their disease, and their treatment?
Policy
What if the government was awarding a contract to fight malaria in a developing country, and an organization bidding for the work had all the technical expertise the work called for, but also a history of criticizing the government? Should that keep the organization from getting the contract? Could one of the strings attached to [...]